Chemical Structure : Merimepodib
CAS No.: 198821-22-6
Catalog No.: PC-35011Not For Human Use, Lab Use Only.
Merimepodib (VX-497, VI-21497, MMPD) is a potent, selective, reversible, uncompetitive IMPDH inhibitor with broad-spectrum antiviral activity.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $128 | In stock | |
10 mg | $188 | In stock | |
25 mg | $328 | In stock | |
50 mg | $528 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Merimepodib (VX-497, VI-21497, MMPD) is a potent, selective, reversible, uncompetitive IMPDH inhibitor with broad-spectrum antiviral activity.
Merimepodib inhibits HBV, HCMV, RSV and HSV-1 with IC50 of 0.4, 0.8, 1.1 and 6.3 uM, also inhibits BVDV, VEEV, Coxsackie B3 and Dengue virus with IC50 at low uM level.
Merimepodib is 17- to 186-fold more potent than ribavirin against HBV, HCMV, RSV, HSV-1, parainfluenza-3 virus, EMCV, and VEEV infections in cultured cells, also demonstrates additivity when coapplied with IFN-alpha.
M.Wt | 452.467 | |
Formula | C23H24N4O6 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-tetrahydrofuran-3-yl (3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl)carbamate |
1. Markland W, et al. Antimicrob Agents Chemother. 2000 Apr;44(4):859-66.
2. Tong X, et al. Antiviral Res. 2018 Jan;149:34-40. doi: 10.1016/j.antiviral.2017.11.004.
3. Beevers RE, et al. Bioorg Med Chem Lett. 2006 May 1;16(9):2535-8.
4. Decker CJ, et al. Drugs Exp Clin Res. 2001;27(3):89-95.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright